,Gene_set,Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
0,KEGG_2021_Human,Complement and coagulation cascades,27/85,1.5326226687876029e-10,4.4752581928598004e-08,0,0,5.531103626711871,124.99669457898791,CPB2;SERPINA1;CFI;C4BPA;C4BPB;C8B;TFPI;C8A;KNG1;C2;C4B;C3;C4A;C5;C6;CD55;FGB;FGA;SERPIND1;FGG;F11;F2;F5;F7;PROC;KLKB1;CFB
1,KEGG_2021_Human,Neuroactive ligand-receptor interaction,61/341,1.0413672006069343e-09,1.5203961128861244e-07,0,0,2.614717970521542,54.07950939568335,GABRB2;PRSS1;GABRB1;NPFFR1;VIPR2;HTR2B;OXT;HTR4;ADRA1B;RXFP2;GABRR3;CYSLTR1;UCN3;ADORA1;PRLHR;PRSS2;INSL5;LHCGR;AVPR1B;GPR35;GLP2R;NPY1R;SSTR1;F2;ADRA2A;GIP;MTNR1A;AGTR1;CRH;AGTR2;OPRD1;PTGFR;CALCA;PTGER2;CHRNA9;KNG1;C3;C5;MC2R;P2RY6;GLRA3;CALCR;NPW;HRH3;P2RY4;KISS1R;TAC4;PRLH;CGA;HCRT;GRIA4;GABBR2;HTR1F;SCTR;AGT;GRIN1;GH2;PYY;SST;GNRH2;RLN3
2,KEGG_2021_Human,Maturity onset diabetes of the young,12/26,1.8314443036913065e-07,1.782605788926205e-05,0,0,10.110551844056008,156.84489731915426,NEUROD1;RFX6;HNF4A;ONECUT1;HNF4G;PDX1;HNF1B;BHLHA15;HNF1A;MNX1;FOXA3;FOXA2
3,KEGG_2021_Human,Bile secretion,17/90,0.0005806199932089815,0.0381649883454858,0,0,2.74692749234074,20.46849416992655,ABCC3;UGT2B11;ABCB4;SLC10A2;UGT2B15;NR1H4;SCTR;AQP4;ATP1B1;BAAT;SLC51B;SLC4A4;NR0B2;SLC4A5;AQP1;UGT2B4;CFTR
4,KEGG_2021_Human,Hematopoietic cell lineage,18/99,0.0006535100744090044,0.0381649883454858,0,0,2.621793497677742,19.22601182759147,GYPA;HLA-DRB5;CSF2;CSF3R;ITGA1;CD1E;CD1C;CD1B;CSF2RA;CD1A;EPOR;GP9;HLA-DMA;THPO;ANPEP;CD55;HLA-DPA1;HLA-DQB1
5,KEGG_2021_Human,Taste transduction,16/86,0.0009873555723784067,0.0480513045224157,0,0,2.6948527387833745,18.64967536481163,KCNK5;TAS2R50;GABBR2;TAS2R30;PDE1C;HTR1F;TAS2R13;TAS2R46;HTR3A;HTR3B;P2RY4;SCNN1B;TAS1R1;TAS2R3;SCN3A;TAS2R4
6,KEGG_2021_Human,Protein digestion and absorption,17/103,0.0027100176802619,0.113046451805213,0,0,2.330042745262151,13.772416938370336,KCNK5;PRSS1;CPB2;COL25A1;KCNJ13;SLC1A1;COL11A2;SLC3A1;ATP1B1;DPP4;MEP1A;SLC7A9;COL4A4;KCNQ1;COL4A3;KCNN4;PRSS2
7,KEGG_2021_Human,cAMP signaling pathway,29/216,0.0032466767863443,0.1185037027015692,0,0,1.8320356875675377,10.497790440323527,VIPR2;NPR1;HHIP;PTGER2;CACNA1D;OXT;HTR4;MC2R;HCAR1;CREB3L3;CREB3L1;ADORA1;CNGA3;CNGA4;CGA;GRIA4;GABBR2;LHCGR;HTR1F;PDE4D;PDE4C;NPY1R;SSTR1;ATP1B1;GRIN1;GIP;SST;PPP1R1B;CFTR
8,KEGG_2021_Human,Histidine metabolism,6/22,0.0058317066810838,0.1892064834307204,0,0,4.405950861518826,22.66617443646835,AOC1;HAL;ALDH2;ALDH3B1;CARNS1;HNMT
9,KEGG_2021_Human,Staphylococcus aureus infection,15/95,0.0071150226497729,0.1986317039281591,0,0,2.2079990372272142,10.919762714410933,HLA-DRB5;FGG;CFI;KRT20;ICAM1;C2;C4B;C3;C4A;C5;HLA-DMA;KRT18;CFB;HLA-DPA1;HLA-DQB1
10,KEGG_2021_Human,Ascorbate and aldarate metabolism,7/30,0.0074827011753758,0.1986317039281591,0,0,3.576767171969571,17.50885271319002,KL;MIOX;UGT2B11;ALDH2;UGT2B15;RGN;UGT2B4
11,KEGG_2021_Human,Asthma,7/31,0.0090225881000175,0.2123141460254887,0,0,3.42754895700298,16.13698294616793,HLA-DMA;HLA-DRB5;CD40LG;PRG2;FCER1A;HLA-DPA1;HLA-DQB1
12,KEGG_2021_Human,Glycerophospholipid metabolism,15/98,0.0094523421175731,0.2123141460254887,0,0,2.12784385294709,9.918928640566053,ACHE;PLA2G12B;PNPLA7;PLA2G1B;PLA2G2C;LPCAT1;PLA2G4A;PLAAT3;CRLS1;ETNPPL;GPD1;PLA2G10;GPD1L;LPIN2;PLA1A
13,KEGG_2021_Human,alpha-Linolenic acid metabolism,6/25,0.0113029669508653,0.2237526140602352,0,0,3.70966983508548,16.629299968391713,PLA2G12B;PLA2G1B;PLA2G2C;PLA2G10;PLA2G4A;PLAAT3
14,KEGG_2021_Human,Intestinal immune network for IgA production,9/48,0.0114941411332312,0.2237526140602352,0,0,2.7131615187881173,12.11675642985774,PIGR;HLA-DMA;HLA-DRB5;CD40LG;TNFSF13;CCR9;IL2;HLA-DPA1;HLA-DQB1
15,KEGG_2021_Human,Pancreatic secretion,15/102,0.0134678241398013,0.2457877905513753,0,0,2.029569297507857,8.742271995624478,PRSS1;CPB2;PLA2G12B;AMY1A;PLA2G1B;PLA2G2C;AMY1B;SCTR;ATP1B1;SLC4A4;KCNQ1;PLA2G10;CLCA1;PRSS2;CFTR
16,KEGG_2021_Human,Retinol metabolism,11/68,0.0164842427106779,0.283141110089292,0,0,2.2695824067210277,9.317430908717144,SDR16C5;ADH4;CYP3A7-CYP3A51P;UGT2B11;ADH1B;ALDH1A2;UGT2B15;AOX1;UGT2B4;HSD17B6;BCO1
17,KEGG_2021_Human,Nicotinate and nicotinamide metabolism,7/35,0.017542239007316,0.284574099452016,0,0,2.9372605363984676,11.875766282271131,NT5E;NMRK2;NT5C1A;QPRT;AOX1;ENPP3;NMNAT2
18,KEGG_2021_Human,"Parathyroid hormone synthesis, secretion and action",15/106,0.0186967821213246,0.2873400199698314,0,0,1.9399342634259191,7.71978187468883,SLC34A3;SLC34A2;GCM1;KL;CASR;MEF2C;PDE4D;PDE4C;ARRB1;NR4A2;MMP24;CYP24A1;CREB3L3;MMP15;CREB3L1
19,KEGG_2021_Human,ECM-receptor interaction,13/88,0.0198086500503661,0.2892062907353459,0,0,2.039111111111111,7.996652694351741,TNXB;ITGA1;THBS4;DSPP;COMP;GP9;IBSP;COL4A4;ITGA10;COL4A3;CHAD;ITGA8;ITGA9
20,KEGG_2021_Human,Linoleic acid metabolism,6/29,0.023182315336364,0.3223445751532531,0,0,3.0638439554951304,11.533428670250956,PLA2G12B;PLA2G1B;PLA2G2C;PLA2G10;PLA2G4A;PLAAT3
21,KEGG_2021_Human,Cytokine-cytokine receptor interaction,33/295,0.0256410406823862,0.340326539966218,0,0,1.4856870229007633,5.442905123728611,CCL14;CX3CR1;CCL13;CSF2;CSF3R;AMHR2;CXCL17;CSF2RA;EDA2R;THPO;CCR9;CCL17;CCL15;GDF10;TNFSF15;GDF15;IL37;TNFSF13;TNFRSF10C;PPBP;GDF5;BMP6;IL2;EPOR;BMP5;TGFBR2;GH2;CD40LG;IFNK;INHA;IL6ST;IL17C;CRLF2
22,KEGG_2021_Human,Renin-angiotensin system,5/23,0.0305066252779535,0.387301503528802,0,0,3.261231575963719,11.381083121174306,ANPEP;AGTR1;REN;AGTR2;AGT
23,KEGG_2021_Human,Thyroid hormone synthesis,11/75,0.0320224845196718,0.3896068949893411,0,0,2.0205765845070425,6.953444513047945,TTR;CREB3L3;IYD;CREB3L1;ALB;LRP2;ATP1B1;CGA;SLC26A4;SERPINA7;SLC5A5
24,KEGG_2021_Human,Metabolism of xenobiotics by cytochrome P450,11/76,0.0348831668433266,0.4044563412520678,0,0,1.989382448537378,6.675871925285742,ADH4;HPGDS;AKR7A3;UGT2B11;GSTA5;ADH1B;ALDH3B1;GSTA2;UGT2B15;UGT2B4;AKR7L
25,KEGG_2021_Human,Ether lipid metabolism,8/49,0.0360132358649101,0.4044563412520678,0,0,2.2923400607807993,7.619437481360893,GAL3ST1;PLA2G12B;PLA2G1B;PLA2G2C;PLA2G10;LPCAT1;PLA2G4A;PLAAT3
26,KEGG_2021_Human,Nitrogen metabolism,4/17,0.0396638524230864,0.4289572187978234,0,0,3.6111192822473894,11.654219514399127,CA1;CA3;CPS1;CA4
27,KEGG_2021_Human,Renin secretion,10/69,0.0426807533059452,0.4406726198397565,0,0,1.991823633386469,6.2822260860335435,PDE1C;NPR1;PTGER2;ADORA1;AGTR1;CLCA1;CACNA1D;REN;AGT;AQP1
28,KEGG_2021_Human,Graft-versus-host disease,7/42,0.0437654314224415,0.4406726198397565,0,0,2.3489144316730526,7.349544227142615,HLA-DMA;HLA-DRB5;KIR2DL1;KIR3DL2;IL2;HLA-DPA1;HLA-DQB1
29,KEGG_2021_Human,Arachidonic acid metabolism,9/61,0.047983776315244,0.4459372729805025,0,0,2.033432520165257,6.175315600961254,HPGDS;PLA2G12B;PLA2G1B;PLA2G2C;PLA2G10;PLA2G4A;PLAAT3;LTA4H;ALOX15B
30,KEGG_2021_Human,Steroid hormone biosynthesis,9/61,0.047983776315244,0.4459372729805025,0,0,2.033432520165257,6.175315600961254,CYP3A7-CYP3A51P;STS;UGT2B11;SRD5A2;CYP21A2;UGT2B15;UGT2B4;HSD17B6;CYP17A1
31,KEGG_2021_Human,Type I diabetes mellitus,7/43,0.0488698381348495,0.4459372729805025,0,0,2.283542642259117,6.893090127872957,HLA-DMA;HLA-DRB5;PTPRN2;ICA1;IL2;HLA-DPA1;HLA-DQB1
32,KEGG_2021_Human,Mucin type O-glycan biosynthesis,6/36,0.0597640102791665,0.4986026000433324,0,0,2.3480536056158265,6.615292662495126,GALNT12;ST6GALNAC1;B3GNT6;B3GNT3;GCNT3;GALNTL6
33,KEGG_2021_Human,Starch and sucrose metabolism,6/36,0.0597640102791665,0.4986026000433324,0,0,2.3480536056158265,6.615292662495126,AMY1A;TREH;AMY1B;HKDC1;ENPP3;G6PC1
34,KEGG_2021_Human,Tyrosine metabolism,6/36,0.0597640102791665,0.4986026000433324,0,0,2.3480536056158265,6.615292662495126,ADH4;HGD;ADH1B;TAT;ALDH3B1;AOX1
35,KEGG_2021_Human,GnRH secretion,9/64,0.0619549974717487,0.502523868381962,0,0,1.9222041385724251,5.346316723281775,GABBR2;TRPC5;KISS1R;GNRH2;ARRB1;CACNA1D;CGA;KCNN4;HCN1
36,KEGG_2021_Human,Carbohydrate digestion and absorption,7/47,0.0729448108003891,0.5442001159570226,0,0,2.054741379310345,5.379420065643099,AMY1A;AMY1B;HKDC1;CACNA1D;ATP1B1;LCT;G6PC1
37,KEGG_2021_Human,Cell adhesion molecules,17/148,0.0736984435596876,0.5442001159570226,0,0,1.5258933652544202,3.979184432193898,HLA-DRB5;CADM1;CLDN2;ICAM1;CLDN6;OCLN;HLA-DMA;CLDN3;CD40LG;CLDN9;CLDN23;ITGA8;CLDN18;CDH15;HLA-DPA1;HLA-DQB1;ITGA9
38,KEGG_2021_Human,Allograft rejection,6/38,0.0742874316831141,0.5442001159570226,0,0,2.201060944479898,5.7223479531991135,HLA-DMA;HLA-DRB5;CD40LG;IL2;HLA-DPA1;HLA-DQB1
39,KEGG_2021_Human,"Phenylalanine, tyrosine and tryptophan biosynthesis",2/6,0.074951460257876,0.5442001159570226,0,0,5.8634627625716105,15.191731111167876,PAH;TAT
40,KEGG_2021_Human,Pantothenate and CoA biosynthesis,4/21,0.0778683828542562,0.5442001159570226,0,0,2.7608442994788738,7.04770463719399,ALDH2;DPYS;GADL1;ENPP3
41,KEGG_2021_Human,Glycolysis / Gluconeogenesis,9/67,0.0782753591445032,0.5442001159570226,0,0,1.8224821412823,4.642814121417805,ADH4;ALDH2;ADH1B;HKDC1;ALDH3B1;ALDOB;ENO3;FBP1;G6PC1
42,KEGG_2021_Human,Drug metabolism,13/108,0.0813657918100551,0.5467400544946347,0,0,1.6080701754385964,4.03432700664117,CDA;UGT2B11;ADH1B;DPYS;UGT2B15;FMO5;ADH4;HPGDS;GSTA5;ALDH3B1;GSTA2;AOX1;UGT2B4
43,KEGG_2021_Human,beta-Alanine metabolism,5/30,0.082385487663575,0.5467400544946347,0,0,2.3471938775510206,5.859407996199044,ALDH2;DPYS;ALDH3B1;CARNS1;GADL1
44,KEGG_2021_Human,Proximal tubule bicarbonate reclamation,4/23,0.1019326945142387,0.6614299288479493,0,0,2.4699607527422764,5.6400134579142875,CA4;ATP1B1;SLC4A4;AQP1
45,KEGG_2021_Human,Tryptophan metabolism,6/42,0.1087774872595508,0.6905005712997576,0,0,1.956073175920017,4.339452267347077,TPH2;AOC1;ALDH2;AOX1;INMT;ACMSD
46,KEGG_2021_Human,Tight junction,18/169,0.1162064947859671,0.7154951460981844,0,0,1.401026383594898,3.0155503343810413,CACNA1D;CD1E;CGN;CLDN2;CD1C;CD1B;CD1A;CLDN6;OCLN;PARD6B;CLDN3;TUBA3C;CLDN9;CLDN23;CLDN18;CFTR;CGNL1;TJP3
47,KEGG_2021_Human,Fat digestion and absorption,6/43,0.1184922451628211,0.7154951460981844,0,0,1.9031028475827456,4.059142835897583,PLA2G12B;PLA2G1B;NPC1L1;PLA2G2C;PLA2G10;APOB
48,KEGG_2021_Human,Autoimmune thyroid disease,7/53,0.120065966297298,0.7154951460981844,0,0,1.7861485923704814,3.7861241203430014,HLA-DMA;HLA-DRB5;CD40LG;CGA;IL2;HLA-DPA1;HLA-DQB1
49,KEGG_2021_Human,Calcium signaling pathway,24/240,0.1335177737568544,0.7547471452679577,0,0,1.306290796929919,2.630243524892363,RET;PTGFR;LHCGR;PDE1C;AVPR1B;TNNC1;TNNC2;HTR2B;VEGFD;CACNA1D;MST1R;HTR4;ADRA1B;MYLK3;GRIN1;GNA14;CYSLTR1;FGF9;ERBB4;ITPKA;FGF18;KDR;AGTR1;MET
50,KEGG_2021_Human,Cortisol synthesis and secretion,8/65,0.1364224404266303,0.7547471452679577,0,0,1.6474412869233788,3.2817014419876394,MC2R;CREB3L3;CYP21A2;CREB3L1;AGTR1;CACNA1D;AGT;CYP17A1
51,KEGG_2021_Human,Regulation of lipolysis in adipocytes,7/55,0.1385795410595389,0.7547471452679577,0,0,1.711539484887186,3.382533993469107,NPR1;ADORA1;NPY1R;AQP7;PLAAT3;CGA;MGLL
52,KEGG_2021_Human,ABC transporters,6/45,0.1391532607415711,0.7547471452679577,0,0,1.8053114721908596,3.560398020215504,ABCC3;ABCB4;ABCA3;ABCC6;ABCA8;CFTR
53,KEGG_2021_Human,Pertussis,9/76,0.1413911327981175,0.7547471452679577,0,0,1.5768981181051265,3.0847678956693687,C4B;C3;C4A;C5;SFTPA2;C4BPA;C4BPB;SFTPA1;C2
54,KEGG_2021_Human,Phenylalanine metabolism,3/17,0.1447460278596083,0.7547471452679577,0,0,2.513148316651501,4.857349243238065,TAT;ALDH3B1;PAH
55,KEGG_2021_Human,Primary bile acid biosynthesis,3/17,0.1447460278596083,0.7547471452679577,0,0,2.513148316651501,4.857349243238065,ACOX2;BAAT;CYP8B1
56,KEGG_2021_Human,Synaptic vesicle cycle,9/78,0.1581659062239974,0.7892734338823949,0,0,1.5310241298787943,2.8233780678533797,UNC13B;DNM3;RIMS1;UNC13A;STXBP1;SLC1A1;CPLX1;SLC1A7;SLC6A3
57,KEGG_2021_Human,Viral protein interaction with cytokine and cytokine receptor,11/100,0.1618754954988271,0.7892734338823949,0,0,1.4510207311283432,2.6422039667009485,CCL14;CX3CR1;CCL13;IL37;TNFRSF10C;CCR9;PPBP;IL6ST;CCL17;IL2;CCL15
58,KEGG_2021_Human,Vascular smooth muscle contraction,14/133,0.1619154680075267,0.7892734338823949,0,0,1.3815794438365467,2.51541528085295,CALCA;PLA2G12B;AVPR1B;NPR1;PLA2G1B;PLA2G2C;PLA2G4A;CACNA1D;ADRA1B;MYLK3;AGT;PLA2G10;AGTR1;RAMP1
59,KEGG_2021_Human,Aldosterone-regulated sodium reabsorption,5/37,0.1621794727155606,0.7892734338823949,0,0,1.8330476721938775,3.3344084855698277,FXYD4;SCNN1B;ATP1B1;KCNJ1;NR3C2
60,KEGG_2021_Human,Systemic lupus erythematosus,14/135,0.1753744101570843,0.821661223637225,0,0,1.358594988311007,2.36508577183449,HLA-DRB5;C8B;C8A;C2;C4B;C3;C4A;C5;HLA-DMA;C6;CD40LG;ELANE;HLA-DPA1;HLA-DQB1
61,KEGG_2021_Human,Morphine addiction,10/91,0.1771608382602819,0.821661223637225,0,0,1.4490967828566463,2.5079478435658578,GABRR3;GABRB2;GABBR2;GABRB1;PDE1C;PDE4D;PDE4C;ADORA1;ARRB1;GNG11
62,KEGG_2021_Human,Serotonergic synapse,12/113,0.1772762229080314,0.821661223637225,0,0,1.3948408293744172,2.4131390505880166,TPH2;GABRB2;GABRB1;HTR1F;HTR2B;PLA2G4A;CACNA1D;HTR3A;HTR3B;HTR4;ALOX15B;GNG11
63,KEGG_2021_Human,Viral myocarditis,7/60,0.1903161558118856,0.868317460891728,0,0,1.5496517988385263,2.5709786585822796,HLA-DMA;HLA-DRB5;CD40LG;CD55;ICAM1;HLA-DPA1;HLA-DQB1
64,KEGG_2021_Human,Salivary secretion,10/93,0.1945328283292345,0.87268886860392,0,0,1.4140246205551572,2.3149765542817176,DMBT1;AMY1A;AMY1B;AQP5;ADRA1B;ATP1B1;KCNN4;LYZ;MUC5B;CST5
65,KEGG_2021_Human,Malaria,6/50,0.1972515935885573,0.87268886860392,0,0,1.5997273307420086,2.5967977671596785,COMP;GYPA;CD40LG;MET;THBS4;ICAM1
66,KEGG_2021_Human,Nicotine addiction,5/40,0.2032925490579205,0.8859914078345194,0,0,1.6756559766763848,2.66950296756758,GABRR3;GABRB2;GABRB1;GRIA4;GRIN1
67,KEGG_2021_Human,Taurine and hypotaurine metabolism,2/11,0.2124793935957702,0.9124115136759544,0,0,2.605276186434684,4.035339032585002,GADL1;BAAT
68,KEGG_2021_Human,Ferroptosis,5/41,0.2177095645107121,0.9213216353206948,0,0,1.6290214002267571,2.483595238337754,TF;MAP1LC3C;ACSL5;SLC39A8;CP
69,KEGG_2021_Human,PPAR signaling pathway,8/74,0.2246911004762936,0.9372828762725391,0,0,1.422093135831155,2.123225875570754,FABP3;ACOX2;AQP7;ACSL5;LPL;HMGCS2;CYP8B1;PLIN5
70,KEGG_2021_Human,Focal adhesion,19/201,0.233584590934866,0.9606577542673362,0,0,1.2256742613885472,1.7823889855665287,TNXB;SHC3;CAV3;RASGRF1;ITGA1;VEGFD;MYLK3;THBS4;COMP;IBSP;COL4A4;ITGA10;COL4A3;CHAD;KDR;ITGA8;PAK3;MET;ITGA9
71,KEGG_2021_Human,Aldosterone synthesis and secretion,10/98,0.2409432731659778,0.9771588300620214,0,0,1.3333187925318444,1.8975709779581176,NR4A2;MC2R;CREB3L3;NPR1;CYP21A2;CREB3L1;AGTR1;CACNA1D;ATP1B1;AGT
72,KEGG_2021_Human,Arrhythmogenic right ventricular cardiomyopathy,8/77,0.2579275545090249,0.9999955952317446,0,0,1.3600407463999629,1.8429592952465863,CACNG6;ACTN3;ITGA10;ITGA1;ITGA8;CACNA2D2;CACNA1D;ITGA9
73,KEGG_2021_Human,Hypertrophic cardiomyopathy,9/90,0.275739004035213,0.9999955952317446,0,0,1.3033532253481102,1.6791106095671755,CACNG6;TNNC1;ITGA10;ITGA1;ITGA8;CACNA2D2;CACNA1D;AGT;ITGA9
74,KEGG_2021_Human,Pyrimidine metabolism,6/56,0.276356827730921,0.9999955952317446,0,0,1.407300574345884,1.8098763459793363,CDA;NT5E;DPYS;NT5C1A;ENTPD8;ENPP3
75,KEGG_2021_Human,Pentose and glucuronate interconversions,4/34,0.2769936035370977,0.9999955952317446,0,0,1.5633736987465476,2.0069979717980675,KL;UGT2B11;UGT2B15;UGT2B4
76,KEGG_2021_Human,Glycosphingolipid biosynthesis,5/45,0.2780901175244091,0.9999955952317446,0,0,1.4658003826530612,1.8759460669707615,FUT9;B3GALT2;B3GNT3;ST3GAL5;ST6GALNAC6
77,KEGG_2021_Human,Amoebiasis,10/102,0.2806427801298501,0.9999955952317446,0,0,1.2750702383932793,1.6201968959118866,GNA14;CSF2;COL4A4;COL4A3;CD1E;CD1C;C8B;CD1B;C8A;CD1A
78,KEGG_2021_Human,Vitamin digestion and absorption,3/24,0.2914718380336531,0.9999955952317446,0,0,1.6747952684258416,2.064707517514412,CUBN;CBLIF;APOB
79,KEGG_2021_Human,Amphetamine addiction,7/69,0.2984953023915854,0.9999955952317446,0,0,1.3240534750545874,1.6007820861580822,CREB3L3;CREB3L1;PPP1R1B;CACNA1D;SLC6A3;GRIA4;GRIN1
80,KEGG_2021_Human,Relaxin signaling pathway,12/129,0.3153824602126782,0.9999955952317446,0,0,1.2030420999030864,1.3882735503398933,SHC3;CREB3L3;CREB3L1;COL4A4;COL4A3;RLN3;ARRB1;VEGFD;GNG11;RXFP2;INSL5;TGFBR2
81,KEGG_2021_Human,"Valine, leucine and isoleucine degradation",5/48,0.325325318792081,0.9999955952317446,0,0,1.363312766967252,1.530904282445128,ACAD8;ALDH2;AGXT2;AOX1;HMGCS2
82,KEGG_2021_Human,Thiamine metabolism,2/15,0.3326052510646709,0.9999955952317446,0,0,1.8032610292317488,1.9850278014276848,AK1;ALPG
83,KEGG_2021_Human,Mineral absorption,6/60,0.3326192823287772,0.9999955952317446,0,0,1.3027724597603347,1.4340355649513403,SLC34A3;SLC34A2;S100G;TF;SLC26A9;ATP1B1
84,KEGG_2021_Human,Folate biosynthesis,3/26,0.3358275333126168,0.9999955952317446,0,0,1.52899473829964,1.66837414421434,TPH2;PAH;ALPG
85,KEGG_2021_Human,"Neomycin, kanamycin and gentamicin biosynthesis",1/5,0.3360964613813458,0.9999955952317446,0,0,2.929866412213741,3.194600564846582,HKDC1
86,KEGG_2021_Human,Cocaine addiction,5/49,0.3412751314381597,0.9999955952317446,0,0,1.332255913729128,1.4322634224428716,CREB3L3;CREB3L1;PPP1R1B;SLC6A3;GRIN1
87,KEGG_2021_Human,Sphingolipid metabolism,5/49,0.3412751314381597,0.9999955952317446,0,0,1.332255913729128,1.4322634224428716,SMPD3;ASAH1;GAL3ST1;SPTLC3;SGMS2
88,KEGG_2021_Human,Dilated cardiomyopathy,9/96,0.3421110267608073,0.9999955952317446,0,0,1.213069935620425,1.301163019698925,CACNG6;TNNC1;ITGA10;ITGA1;ITGA8;CACNA2D2;CACNA1D;AGT;ITGA9
89,KEGG_2021_Human,Arginine and proline metabolism,5/50,0.3572777434652383,0.9999955952317446,0,0,1.3025793650793651,1.340669139191591,AOC1;ALDH2;CARNS1;PRODH;PRODH2
90,KEGG_2021_Human,Cholesterol metabolism,5/50,0.3572777434652383,0.9999955952317446,0,0,1.3025793650793651,1.340669139191591,NPC2;APOH;LPL;LRP2;APOB
91,KEGG_2021_Human,Cysteine and methionine metabolism,5/50,0.3572777434652383,0.9999955952317446,0,0,1.3025793650793651,1.340669139191591,AHCYL2;BHMT;AGXT2;TAT;BHMT2
92,KEGG_2021_Human,Coronavirus disease,20/232,0.367772287210763,0.9999955952317446,0,0,1.106501111664581,1.1068234543516842,FGB;NRP1;FGA;CSF2;FGG;TMPRSS2;C8B;F2;C8A;IL2;C2;C4B;C3;C4A;C5;C6;AGTR1;IL6ST;CFB;TLR3
93,KEGG_2021_Human,Ovarian steroidogenesis,5/51,0.3733047685332985,0.9999955952317446,0,0,1.2741931011535048,1.25553906596712,LHCGR;PLA2G4A;CGA;BMP6;CYP17A1
94,KEGG_2021_Human,Butanoate metabolism,3/28,0.3800278124829589,0.9999955952317446,0,0,1.4065222929936303,1.3608255626347676,ACSM3;ACSM1;HMGCS2
95,KEGG_2021_Human,"Glycine, serine and threonine metabolism",4/40,0.3866984361113236,0.9999955952317446,0,0,1.302386516535656,1.2374106154615143,DMGDH;BHMT;AGXT2;CHDH
96,KEGG_2021_Human,Vitamin B6 metabolism,1/6,0.3883254502282771,0.9999955952317446,0,0,2.343765903307888,2.2169951252261515,AOX1
97,KEGG_2021_Human,Adrenergic signaling in cardiomyocytes,13/150,0.3997288385546803,0.9999955952317446,0,0,1.112530413625304,1.0201557510693933,TNNC1;CACNA2D2;CACNA1D;ATP1B1;ADRA1B;AGT;CACNG6;CREB3L3;CREB3L1;KCNQ1;AGTR1;SCN7A;AGTR2
98,KEGG_2021_Human,Inflammatory bowel disease,6/65,0.4044625030936142,0.9999955952317446,0,0,1.1920435248180157,1.0790333239462802,HLA-DMA;HLA-DRB5;RORC;IL2;HLA-DPA1;HLA-DQB1
99,KEGG_2021_Human,Fatty acid biosynthesis,2/18,0.4194407142643577,0.9999955952317446,0,0,1.46491088478676,1.2727630474094616,OLAH;ACSL5
100,KEGG_2021_Human,Pentose phosphate pathway,3/30,0.4235519540792648,0.9999955952317446,0,0,1.3021939136588818,1.1186875682631685,RGN;ALDOB;FBP1
101,KEGG_2021_Human,Purine metabolism,11/129,0.4359206234448073,0.9999955952317446,0,0,1.0926832179517785,0.9072495310344832,GUCY2C;NT5E;PDE1C;NPR1;PDE4D;NT5C1A;AK1;PDE4C;ENTPD8;ENPP4;ENPP3
102,KEGG_2021_Human,PI3K-Akt signaling pathway,29/354,0.4373909538799788,0.9999955952317446,0,0,1.0461498605021922,0.8650904575657824,TNXB;CSF3R;EFNA5;THBS4;COMP;CREB3L3;FGF9;IBSP;ERBB4;CREB3L1;CHAD;KDR;ITGA1;VEGFD;GNG11;G6PC1;IL2;EPOR;EREG;GH2;COL4A4;EIF4E1B;ITGA10;COL4A3;FGF18;ITGA8;SGK2;MET;ITGA9
103,KEGG_2021_Human,Fatty acid degradation,4/43,0.4411505851062787,0.9999955952317446,0,0,1.2020068310699286,0.9836851271271588,ADH4;ALDH2;ADH1B;ACSL5
104,KEGG_2021_Human,Porphyrin and chlorophyll metabolism,4/43,0.4411505851062787,0.9999955952317446,0,0,1.2020068310699286,0.9836851271271588,UGT2B11;UGT2B15;UGT2B4;CP
105,KEGG_2021_Human,cGMP-PKG signaling pathway,14/167,0.4423261536551613,0.9999955952317446,0,0,1.0725662084376193,0.8749005845111401,OPRD1;MEF2C;TRPC6;NPR1;CACNA1D;ATP1B1;ADRA1B;MYLK3;KNG1;ADRA2A;CREB3L3;CREB3L1;ADORA1;AGTR1
106,KEGG_2021_Human,Galactose metabolism,3/31,0.4449234650873684,0.9999955952317446,0,0,1.2556187443130118,1.016866607158283,HKDC1;LCT;G6PC1
107,KEGG_2021_Human,Vasopressin-regulated water reabsorption,4/44,0.4590003677171484,0.9999955952317446,0,0,1.1718929254302104,0.9125580224315394,CREB3L3;CREB3L1;AQP4;AQP2
108,KEGG_2021_Human,Ras signaling pathway,19/232,0.4618472497752783,0.9999955952317446,0,0,1.0455102990314258,0.8076787357004429,SHC3;PLA2G12B;PLA2G1B;PLA2G2C;RASGRF1;PLA2G4A;PLAAT3;VEGFD;EFNA5;GNG11;GRIN1;FGF9;RASA4;PLA2G10;FGF18;KDR;PAK3;MET;PLA1A
109,KEGG_2021_Human,TGF-beta signaling pathway,8/94,0.4621055566947363,0.9999955952317446,0,0,1.0901850063154763,0.8415813284040302,GREM2;LEFTY1;AMHR2;LEFTY2;GDF5;BMP6;TGFBR2;BMP5
110,KEGG_2021_Human,Prolactin signaling pathway,6/70,0.4756842557279467,0.9999955952317446,0,0,1.098615985960434,0.8162727466899419,LHCGR;SHC3;CISH;CGA;ESR1;CYP17A1
111,KEGG_2021_Human,Riboflavin metabolism,1/8,0.4807868046260237,0.9999955952317446,0,0,1.673936750272628,1.2258763446731926,ENPP3
112,KEGG_2021_Human,Fructose and mannose metabolism,3/33,0.4866599182460814,0.9999955952317446,0,0,1.1717834394904458,0.8439063867907858,HKDC1;ALDOB;FBP1
113,KEGG_2021_Human,Insulin secretion,7/86,0.5196023816454572,0.9999955952317446,0,0,1.0381686793733935,0.6796801171219774,CREB3L3;CREB3L1;PDX1;CACNA1D;ATP1B1;KCNN4;GIP
114,KEGG_2021_Human,Phagosome,12/152,0.5381351874257355,0.9999955952317446,0,0,1.0041365425093804,0.6222086624806443,COMP;C3;HLA-DRB5;HLA-DMA;TUBA3C;SFTPA2;MRC1;SFTPD;SFTPA1;THBS4;HLA-DPA1;HLA-DQB1
115,KEGG_2021_Human,Mannose type O-glycan biosynthesis,2/23,0.5497768116872115,0.9999955952317446,0,0,1.1158194659149463,0.6675310509001458,FUT9;B3GAT1
116,KEGG_2021_Human,Gastric acid secretion,6/76,0.5574531546273223,0.9999955952317446,0,0,1.0041207038016229,0.5867848504818534,SST;KCNQ1;ATP1B1;KCNJ1;MYLK3;CFTR
117,KEGG_2021_Human,Sulfur metabolism,1/10,0.5592791026708174,0.9999955952317446,0,0,1.3018094430308171,0.756490112943016,SELENBP1
118,KEGG_2021_Human,Synthesis and degradation of ketone bodies,1/10,0.5592791026708174,0.9999955952317446,0,0,1.3018094430308171,0.756490112943016,HMGCS2
119,KEGG_2021_Human,"Alanine, aspartate and glutamate metabolism",3/37,0.5651596735900964,0.9999955952317446,0,0,1.0337017609591608,0.589878787737605,CPS1;AGXT2;ASRGL1
120,KEGG_2021_Human,Leishmaniasis,6/77,0.570507394162986,0.9999955952317446,0,0,0.989924229486684,0.5555743328075212,C3;HLA-DMA;HLA-DRB5;EEF1A2;HLA-DPA1;HLA-DQB1
121,KEGG_2021_Human,Antigen processing and presentation,6/78,0.5833701227621022,0.9999955952317446,0,0,0.9761221016804936,0.5260648373641916,HLA-DMA;HLA-DRB5;KIR2DL1;KIR3DL2;HLA-DPA1;HLA-DQB1
122,KEGG_2021_Human,Ubiquinone and other terpenoid-quinone biosynthesis,1/11,0.5939590486050885,0.9999955952317446,0,0,1.171564885496183,0.6103207564980502,TAT
123,KEGG_2021_Human,Dopaminergic synapse,10/132,0.596194442078371,0.9999955952317446,0,0,0.9599551094469442,0.496477666349992,CREB3L3;CALY;CREB3L1;PPP1R1B;CACNA1D;ARRB1;GNG11;SLC6A3;SCN1A;GRIA4
124,KEGG_2021_Human,Rheumatoid arthritis,7/93,0.6041093424374631,0.9999955952317446,0,0,0.9533027413941608,0.4804646454441103,HLA-DMA;HLA-DRB5;CSF2;TNFSF13;ICAM1;HLA-DPA1;HLA-DQB1
125,KEGG_2021_Human,Endocrine and other factor-regulated calcium reabsorption,4/53,0.6079802156338042,0.9999955952317446,0,0,0.9561790299293712,0.4758070559751252,DNM3;KL;ATP1B1;ESR1
126,KEGG_2021_Human,Chemical carcinogenesis,18/239,0.6114543828573564,0.9999955952317446,0,0,0.9535959028677016,0.4690880574199705,CYP3A7-CYP3A51P;UGT2B11;UGT2B15;CHRNA9;CACNA1D;ARRB1;ESR1;HPGDS;GSTA5;CREB3L3;FGF9;CREB3L1;RPS6KA2;GSTA2;FGF18;KPNA7;UGT2B4;SULT1A2
127,KEGG_2021_Human,Th17 cell differentiation,8/107,0.6115434654206262,0.9999955952317446,0,0,0.946358150192016,0.4653898343254508,HLA-DRB5;HLA-DMA;RORC;IL6ST;IL2;HLA-DPA1;TGFBR2;HLA-DQB1
128,KEGG_2021_Human,JAK-STAT signaling pathway,12/162,0.6283842205979485,0.9999955952317446,0,0,0.9366816143497758,0.4351855408246928,GH2;CSF2;CSF3R;CISH;THPO;IFNK;AOX1;IL6ST;CSF2RA;IL2;EPOR;CRLF2
129,KEGG_2021_Human,Hedgehog signaling pathway,4/56,0.6516893058131619,0.9999955952317446,0,0,0.900867774672746,0.3857401900526188,HHIP;IHH;ARRB1;LRP2
130,KEGG_2021_Human,Glutathione metabolism,4/57,0.6655127624211896,0.9999955952317446,0,0,0.8838221677068677,0.3598901454400532,HPGDS;GSTA5;ANPEP;GSTA2
131,KEGG_2021_Human,AGE-RAGE signaling pathway in diabetic complications,7/100,0.6801239241210996,0.9999955952317446,0,0,0.881212320960189,0.3396899511281633,COL4A4;COL4A3;AGTR1;VEGFD;AGT;ICAM1;TGFBR2
132,KEGG_2021_Human,Leukocyte transendothelial migration,8/114,0.6823194073017926,0.9999955952317446,0,0,0.8835252275604316,0.3377340489204008,CLDN6;OCLN;CLDN3;CLDN9;CLDN23;CLDN18;CLDN2;ICAM1
133,KEGG_2021_Human,Cushing syndrome,11/155,0.6824600992313666,0.9999955952317446,0,0,0.8941216744913928,0.3416002732566739,MC2R;RASD1;CREB3L3;FZD4;CYP21A2;CREB3L1;AGTR1;CRH;CACNA1D;AGT;CYP17A1
134,KEGG_2021_Human,Inositol phosphate metabolism,5/73,0.6896894275866401,0.9999955952317446,0,0,0.860922493997599,0.3198446627236129,MIOX;PIP5KL1;ITPKA;PLCH1;MTMR7
135,KEGG_2021_Human,Notch signaling pathway,4/59,0.6920175545751044,0.9999955952317446,0,0,0.8515904745350252,0.3135078860195871,LFNG;TLE2;PSEN2;DTX4
136,KEGG_2021_Human,GABAergic synapse,6/89,0.710314367261388,0.9999955952317446,0,0,0.846249067745135,0.2894574932164918,GABRR3;GABRB2;GABBR2;GABRB1;CACNA1D;GNG11
137,KEGG_2021_Human,Type II diabetes mellitus,3/46,0.7123424383366291,0.9999955952317446,0,0,0.8169456376833062,0.2771051258854861,HKDC1;PDX1;CACNA1D
138,KEGG_2021_Human,Glycerolipid metabolism,4/61,0.7169913231172398,0.9999955952317446,0,0,0.8216206545682243,0.2733462409506585,ALDH2;LPL;LPIN2;MGLL
139,KEGG_2021_Human,Other types of O-glycan biosynthesis,3/47,0.7260534536518504,0.9999955952317446,0,0,0.798335263462652,0.2555723765618566,GALNT12;LFNG;GALNTL6
140,KEGG_2021_Human,Pyruvate metabolism,3/47,0.7260534536518504,0.9999955952317446,0,0,0.798335263462652,0.2555723765618566,ADH4;ALDH2;ADH1B
141,KEGG_2021_Human,"Growth hormone synthesis, secretion and action",8/119,0.7276429528407096,0.9999955952317446,0,0,0.8434965316754454,0.2681853364773236,GH2;SHC3;CREB3L3;SST;CREB3L1;CACNA1D;IGFALS;SSTR1
142,KEGG_2021_Human,Retrograde endocannabinoid signaling,10/148,0.7360088246374948,0.9999955952317446,0,0,0.8479141747104695,0.2598968618570169,GABRR3;RIMS1;ND6;GABRB2;GABRB1;CACNA1D;NDUFV2;GNG11;MGLL;GRIA4
143,KEGG_2021_Human,Selenocompound metabolism,1/17,0.7517048044937724,0.9999955952317446,0,0,0.7319895038167938,0.2089182803262464,INMT
144,KEGG_2021_Human,Other glycan degradation,1/18,0.7712497219889906,0.9999955952317446,0,0,0.6888938781619518,0.1789354068435475,FUCA1
145,KEGG_2021_Human,Pathogenic Escherichia coli infection,13/197,0.7832349663785002,0.9999955952317446,0,0,0.8262228260869565,0.2018648621468698,CLDN2;F2;CLDN6;OCLN;CLDN3;TUBA3C;CLDN9;MYO1A;MYO5C;CLDN23;CLDN18;PAK3;MYO1G
146,KEGG_2021_Human,Circadian entrainment,6/97,0.7842602342192762,0.9999955952317446,0,0,0.7715169323337798,0.1874897107502007,MTNR1A;RASD1;CACNA1D;GNG11;GRIA4;GRIN1
147,KEGG_2021_Human,Glycosaminoglycan degradation,1/19,0.7892570222045354,0.9999955952317446,0,0,0.6505866553576477,0.1539699550417709,HYAL1
148,KEGG_2021_Human,Cholinergic synapse,7/113,0.7946638828019156,0.9999955952317446,0,0,0.7725909058049591,0.1775692363827295,ACHE;CREB3L3;CREB3L1;KCNQ1;KCNQ3;CACNA1D;GNG11
149,KEGG_2021_Human,African trypanosomiasis,2/37,0.7995266085541702,0.9999955952317446,0,0,0.6689824497590252,0.1496750999876528,KNG1;ICAM1
150,KEGG_2021_Human,Adipocytokine signaling pathway,4/69,0.8018983080689654,0.9999955952317446,0,0,0.7201843408344364,0.1589976010603761,ACSL5;AGRP;PPARGC1A;G6PC1
151,KEGG_2021_Human,Glutamatergic synapse,7/114,0.8020135116342981,0.9999955952317446,0,0,0.7653286544681969,0.1688543262098389,SLC1A1;PLA2G4A;CACNA1D;SLC1A7;GNG11;GRIA4;GRIN1
152,KEGG_2021_Human,Steroid biosynthesis,1/20,0.8058475997287093,0.9999955952317446,0,0,0.616311771795902,0.1330374513893004,CYP24A1
153,KEGG_2021_Human,Adherens junction,4/71,0.8195646491829773,0.9999955952317446,0,0,0.6986101994806084,0.1390108514574991,PTPRB;LMO7;MET;TGFBR2
154,KEGG_2021_Human,Longevity regulating pathway,6/102,0.8226328725608806,0.9999955952317446,0,0,0.7311343331206126,0.1427505145760937,KL;CREB3L3;CREB3L1;EIF4E1B;PPARGC1A;FOXA2
155,KEGG_2021_Human,Cardiac muscle contraction,5/87,0.8239845538347497,0.9999955952317446,0,0,0.7133913016426082,0.1381150490113559,CACNG6;TNNC1;CACNA2D2;CACNA1D;ATP1B1
156,KEGG_2021_Human,Phospholipase D signaling pathway,9/148,0.8318183796144392,0.9999955952317446,0,0,0.7571068464921158,0.1394145297189438,DNM3;PTGFR;SHC3;AVPR1B;AGTR1;FCER1A;PLA2G4A;F2;AGT
157,KEGG_2021_Human,Transcriptional misregulation in cancer,12/192,0.8338537566632395,0.9999955952317446,0,0,0.7792867819773649,0.141594260354302,MEF2C;CSF2;HPGD;PAX7;ZBTB16;TMPRSS2;PROM1;MET;ELANE;DUSP6;TGFBR2;BAIAP3
158,KEGG_2021_Human,Arginine biosynthesis,1/22,0.8352154131379077,0.9999955952317446,0,0,0.557554828547195,0.1003964489706975,CPS1
159,KEGG_2021_Human,Terpenoid backbone biosynthesis,1/22,0.8352154131379077,0.9999955952317446,0,0,0.557554828547195,0.1003964489706975,HMGCS2
160,KEGG_2021_Human,Sphingolipid signaling pathway,7/119,0.8357691397811251,0.9999955952317446,0,0,0.7309626436781609,0.1311367834349926,OPRD1;ASAH1;SPTLC3;ADORA1;FCER1A;SGMS2;KNG1
161,KEGG_2021_Human,AMPK signaling pathway,7/120,0.8419396132711955,0.9999955952317446,0,0,0.7244543903073045,0.1246401939968661,CREB3L3;CREB3L1;HNF4A;PPARGC1A;G6PC1;FBP1;CFTR
162,KEGG_2021_Human,Bladder cancer,2/41,0.8437459466344033,0.9999955952317446,0,0,0.600238293427345,0.1019827914460175,DAPK1;UPK3A
163,KEGG_2021_Human,MAPK signaling pathway,19/294,0.8439827819064059,0.9999955952317446,0,0,0.807038727038727,0.1368924794431966,DUSP4;MEF2C;RASGRF1;CACNA2D2;PLA2G4A;VEGFD;CACNA1D;ARRB1;EFNA5;DUSP6;EREG;TGFBR2;CACNG6;FGF9;ERBB4;RPS6KA2;FGF18;KDR;MET
164,KEGG_2021_Human,Estrogen signaling pathway,8/137,0.853256141811587,0.9999955952317446,0,0,0.7250860638482304,0.1150678904298835,GABBR2;SHC3;KRT18;CREB3L3;CREB3L1;TFF1;KRT20;ESR1
165,KEGG_2021_Human,Axon guidance,11/182,0.8559545071097645,0.9999955952317446,0,0,0.7518326332262582,0.1169385818130289,NRP1;TRPC5;PARD6B;TRPC6;DPYSL2;SEMA3B;SEMA3E;EFNA5;PAK3;MET;RND1
166,KEGG_2021_Human,Th1 and Th2 cell differentiation,5/92,0.8587897766582501,0.9999955952317446,0,0,0.6722085385878489,0.1023310568646966,HLA-DMA;HLA-DRB5;IL2;HLA-DPA1;HLA-DQB1
167,KEGG_2021_Human,Insulin resistance,6/108,0.8612946775830546,0.9999955952317446,0,0,0.6879011974923983,0.1027164318622539,CREB3L3;CREB3L1;RPS6KA2;PPARGC1A;G6PC1;AGT
168,KEGG_2021_Human,Platelet activation,7/124,0.8647842855240702,0.9999955952317446,0,0,0.6995338987676153,0.1016249158911915,FGB;GP9;FGA;FGG;PLA2G4A;F2;MYLK3
169,KEGG_2021_Human,Bacterial invasion of epithelial cells,4/77,0.8648957392984405,0.9999955952317446,0,0,0.640980643809424,0.0930359764596698,DNM3;SHC3;CAV3;MET
170,KEGG_2021_Human,IL-17 signaling pathway,5/94,0.871003931291731,0.9999955952317446,0,0,0.6570310708553084,0.090741765269483,CSF2;MUC5B;CCL17;IL17C;MUC5AC
171,KEGG_2021_Human,Influenza A,10/172,0.8775297234461183,0.9999955952317446,0,0,0.721349415100748,0.0942402985622289,PRSS1;HLA-DRB5;HLA-DMA;KPNA7;TMPRSS2;PRSS2;TLR3;ICAM1;HLA-DPA1;HLA-DQB1
172,KEGG_2021_Human,Hepatitis C,9/157,0.8776393936726726,0.9999955952317446,0,0,0.7107166309532038,0.0927623672810629,CLDN6;OCLN;CLDN3;CLDN9;CLDN23;IFIT1B;CLDN18;CLDN2;TLR3
173,KEGG_2021_Human,Toxoplasmosis,6/112,0.882986388219694,0.9999955952317446,0,0,0.6617981722074388,0.082357800387072,HLA-DRB5;HLA-DMA;CD40LG;BIRC7;HLA-DPA1;HLA-DQB1
174,KEGG_2021_Human,Lysosome,7/128,0.8848486217463816,0.9999955952317446,0,0,0.6762610430322029,0.0827328951602683,NAPSA;ASAH1;HYAL1;NPC2;FUCA1;CTSH;CTSE
175,KEGG_2021_Human,Huntington disease,19/306,0.8861925391302952,0.9999955952317446,0,0,0.7727837344562083,0.0933685338722456,DNAH12;ND6;DNAI2;DNAH10;DNAH2;DNAH7;BECN2;DNAH5;DNAH6;DNAH9;DNALI1;GRIN1;TUBA3C;CREB3L3;CREB3L1;NDUFV2;PPARGC1A;DNAI1;GRIA4
176,KEGG_2021_Human,Biosynthesis of unsaturated fatty acids,1/27,0.8906498613826882,0.9999955952317446,0,0,0.4502104129966725,0.0521361222668153,BAAT
177,KEGG_2021_Human,Inflammatory mediator regulation of TRP channels,5/98,0.8927607420527001,0.9999955952317446,0,0,0.6286345183234584,0.0713102001426068,PTGER2;HTR2B;PLA2G4A;TRPM8;KNG1
178,KEGG_2021_Human,Peroxisome,4/82,0.8948524670129738,0.9999955952317446,0,0,0.5997287182755634,0.066627710945627,ACOX2;ACSL5;HAO1;BAAT
179,KEGG_2021_Human,Chemokine signaling pathway,11/192,0.897093989732023,0.9999955952317446,0,0,0.7099058439031982,0.0770919696254543,GRK1;CCL14;CX3CR1;CCL13;SHC3;CCR9;ARRB1;PPBP;GNG11;CCL17;CCL15
180,KEGG_2021_Human,Phototransduction,1/28,0.8992617345250408,0.9999955952317446,0,0,0.4335123927999246,0.0460308432172005,GRK1
181,KEGG_2021_Human,Amino sugar and nucleotide sugar metabolism,2/48,0.9003351185245649,0.9999955952317446,0,0,0.5087039548335317,0.0534079283451748,CHIA;HKDC1
182,KEGG_2021_Human,Acute myeloid leukemia,3/67,0.9059725623831222,0.9999955952317446,0,0,0.5482583598726115,0.0541384613137778,CSF2;ZBTB16;DUSP6
183,KEGG_2021_Human,Gastric cancer,8/149,0.9075539416520692,0.9999955952317446,0,0,0.6629415630027418,0.0643068396525804,SHC3;FGF9;FZD4;REG4;FGF18;CDH17;MET;TGFBR2
184,KEGG_2021_Human,ErbB signaling pathway,4/85,0.9098806568964856,0.9999955952317446,0,0,0.5774221215054017,0.0545328043430391,SHC3;ERBB4;PAK3;EREG
185,KEGG_2021_Human,Fc epsilon RI signaling pathway,3/68,0.9112073359096132,0.9999955952317446,0,0,0.5397942185203332,0.0501926661187743,CSF2;FCER1A;PLA2G4A
186,KEGG_2021_Human,Chagas disease,5/102,0.9112742180090366,0.9999955952317446,0,0,0.6025799495055755,0.0559865583636158,C3;GNA14;KNG1;IL2;TGFBR2
187,KEGG_2021_Human,Vibrio cholerae infection,2/50,0.9125891555523,0.9999955952317446,0,0,0.4874549119456821,0.0445872539404299,KCNQ1;CFTR
188,KEGG_2021_Human,Glyoxylate and dicarboxylate metabolism,1/30,0.9145052685840728,0.9999955952317446,0,0,0.4035711152057559,0.0360679778884418,HAO1
189,KEGG_2021_Human,NF-kappa B signaling pathway,5/104,0.9194332101628382,0.9999955952317446,0,0,0.5903421974850547,0.049587489935507,CCL13;CD40LG;LBP;EDA2R;ICAM1
190,KEGG_2021_Human,Central carbon metabolism in cancer,3/70,0.9208897345125204,0.9999955952317446,0,0,0.5236239186234433,0.0431544514038171,RET;HKDC1;MET
191,KEGG_2021_Human,Apelin signaling pathway,7/137,0.9210081195208027,0.9999955952317446,0,0,0.6291335101679929,0.0517691485206617,MEF2C;BECN2;AGTR1;PPARGC1A;GNG11;MYLK3;KLF2
192,KEGG_2021_Human,Circadian rhythm,1/31,0.9212393815061982,0.9999955952317446,0,0,0.39009754028838,0.0320017928257987,RORC
193,KEGG_2021_Human,Oxytocin signaling pathway,8/154,0.9245367398826922,0.9999955952317446,0,0,0.6400630224517484,0.050220937648008,CACNG6;MEF2C;NPR1;CACNA2D2;PLA2G4A;CACNA1D;OXT;MYLK3
194,KEGG_2021_Human,Fluid shear stress and atherosclerosis,7/139,0.9275546116267788,0.9999955952317446,0,0,0.6195334571771354,0.0465911498772252,MEF2C;GSTA5;CAV3;GSTA2;KDR;KLF2;ICAM1
195,KEGG_2021_Human,Melanoma,3/72,0.9295973508841314,0.9999955952317446,0,0,0.5083910274162282,0.0371144477188269,FGF9;FGF18;MET
196,KEGG_2021_Human,Glucagon signaling pathway,5/107,0.9304289048329456,0.9999955952317446,0,0,0.5728854041616647,0.0413105437315709,CREB3L3;CREB3L1;PPARGC1A;G6PC1;FBP1
197,KEGG_2021_Human,SNARE interactions in vesicular transport,1/33,0.9331589390879552,0.9999955952317446,0,0,0.3656766857506361,0.0252974180161192,VAMP5
198,KEGG_2021_Human,HIF-1 signaling pathway,5/109,0.936995302814559,0.9999955952317446,0,0,0.5618070545525903,0.0365607231729285,TF;EIF4E1B;HKDC1;ALDOB;ENO3
199,KEGG_2021_Human,GnRH signaling pathway,4/93,0.941022883890699,0.9999955952317446,0,0,0.5252898504021025,0.0319312253987448,GNRH2;PLA2G4A;CACNA1D;CGA
200,KEGG_2021_Human,Legionellosis,2/57,0.9452131891904926,0.9999955952317446,0,0,0.4252531682194317,0.023960796167058,C3;EEF1A2
201,KEGG_2021_Human,TNF signaling pathway,5/112,0.9458042908693642,0.9999955952317446,0,0,0.5459660499713904,0.0304210164809323,CSF2;CREB3L3;CREB3L1;VEGFD;ICAM1
202,KEGG_2021_Human,Thyroid cancer,1/37,0.951861698910499,0.9999955952317446,0,0,0.324975261521063,0.0160328264383321,RET
203,KEGG_2021_Human,VEGF signaling pathway,2/59,0.952156796530399,0.9999955952317446,0,0,0.4102873351424391,0.0201145645260787,KDR;PLA2G4A
204,KEGG_2021_Human,Prostate cancer,4/97,0.952591035409027,0.9999955952317446,0,0,0.502587087179698,0.0244104544507511,CREB3L3;SRD5A2;CREB3L1;TMPRSS2
205,KEGG_2021_Human,Choline metabolism in cancer,4/98,0.9551369917872836,0.9999955952317446,0,0,0.4972132948212033,0.0228223397792953,SLC22A3;SLC44A3;SLC44A4;PLA2G4A
206,KEGG_2021_Human,Long-term depression,2/60,0.9553050723675562,0.9999955952317446,0,0,0.4031914660111065,0.018435745125135,CRH;PLA2G4A
207,KEGG_2021_Human,Primary immunodeficiency,1/38,0.955654628094996,0.9999955952317446,0,0,0.3161749535795337,0.0143412845149256,CD40LG
208,KEGG_2021_Human,Thermogenesis,12/232,0.958070953110747,0.9999955952317446,0,0,0.6362005707297187,0.0272506589513756,KLB;ND6;CREB3L3;NPR1;CREB3L1;RPS6KA2;PRDM16;ACSL5;NDUFV2;PPARGC1A;MGLL;COX20
209,KEGG_2021_Human,Various types of N-glycan biosynthesis,1/39,0.9591488634155227,0.9999955952317446,0,0,0.3078378197401901,0.0128396040501212,MGAT4A
210,KEGG_2021_Human,Regulation of actin cytoskeleton,11/218,0.9609593620130562,0.9999955952317446,0,0,0.6198543920527999,0.0246845594494949,SCIN;FGF9;ITGA10;FGF18;ITGA1;ITGA8;F2;PAK3;MYLK3;KNG1;ITGA9
211,KEGG_2021_Human,Human T-cell leukemia virus 1 infection,11/219,0.962481889947686,0.9999955952317446,0,0,0.616840465872156,0.0235879970787836,NRP1;HLA-DRB5;HLA-DMA;CSF2;CREB3L3;CREB3L1;IL2;ICAM1;HLA-DPA1;HLA-DQB1;TGFBR2
212,KEGG_2021_Human,Insulin signaling pathway,6/137,0.9632807273829626,0.9999955952317446,0,0,0.5347700911451356,0.0200059610326205,SHC3;EIF4E1B;HKDC1;PPARGC1A;G6PC1;FBP1
213,KEGG_2021_Human,Basal cell carcinoma,2/63,0.9636031009649402,0.9999955952317446,0,0,0.383299767298682,0.0142111417341024,FZD4;HHIP
214,KEGG_2021_Human,Lysine degradation,2/63,0.9636031009649402,0.9999955952317446,0,0,0.383299767298682,0.0142111417341024,ALDH2;PRDM16
215,KEGG_2021_Human,Thyroid hormone signaling pathway,5/121,0.9659448092870784,0.9999955952317446,0,0,0.5033592100633357,0.0174406816799112,SLCO1C1;RCAN2;DIO1;ATP1B1;ESR1
216,KEGG_2021_Human,T cell receptor signaling pathway,4/104,0.9679409790169332,0.9999955952317446,0,0,0.467227533460803,0.0152242193485735,CSF2;CD40LG;PAK3;IL2
217,KEGG_2021_Human,Amyotrophic lateral sclerosis,20/364,0.9688993897473804,0.9999955952317446,0,0,0.676971802512766,0.021388586583941,DNAH12;ND6;DNAI2;DNAH10;DNAH2;DNAH7;BECN2;DNAH5;DNAH6;DNAH9;DNALI1;GRIN1;TUBA3C;NUP210L;ERBB4;MATR3;ANG;NDUFV2;DNAI1;UBQLN3
218,KEGG_2021_Human,Rap1 signaling pathway,10/210,0.9720754756043828,0.9999955952317446,0,0,0.5830774152271273,0.0165138181117126,PARD6B;FGF9;MAGI3;FGF18;KDR;VEGFD;EFNA5;MET;RAP1GAP;GRIN1
219,KEGG_2021_Human,Long-term potentiation,2/67,0.9723919915268564,0.9999955952317446,0,0,0.3596337462664642,0.0100684043084434,RPS6KA2;GRIN1
220,KEGG_2021_Human,Signaling pathways regulating pluripotency of stem cells,6/143,0.972783999339622,0.9999955952317446,0,0,0.5111818109829094,0.0141051501015788,LEFTY1;HOXD1;FZD4;ONECUT1;IL6ST;LEFTY2
221,KEGG_2021_Human,Mitophagy,2/68,0.9742460539715811,0.9999955952317446,0,0,0.354165461103717,0.009240667433285,CITED2;BECN2
222,KEGG_2021_Human,Basal transcription factors,1/45,0.9750365589647528,0.9999955952317446,0,0,0.2657731899144113,0.0067188292455,TAF1L
223,KEGG_2021_Human,Renal cell carcinoma,2/69,0.9759794732764852,0.9999955952317446,0,0,0.3488604083338875,0.0084820957766777,PAK3;MET
224,KEGG_2021_Human,Small cell lung cancer,3/92,0.9792083541774592,0.9999955952317446,0,0,0.3937164531596651,0.0082723116801927,COL4A4;COL4A3;BIRC7
225,KEGG_2021_Human,Wnt signaling pathway,7/166,0.9793195060720749,0.9999955952317446,0,0,0.5135706081271034,0.0107322545128794,TLE2;DAAM2;FZD4;CTNND2;ROR1;RSPO1;CXXC4
226,KEGG_2021_Human,Natural killer cell mediated cytotoxicity,5/131,0.9800872000117212,0.9999955952317446,0,0,0.4631569889860706,0.0093158153985571,CSF2;SHC3;KIR2DL1;KIR3DL2;ICAM1
227,KEGG_2021_Human,Human papillomavirus infection,17/331,0.9803588914330196,0.9999955952317446,0,0,0.6302314443371048,0.012501622983559,TNXB;FZD4;ITGA1;THBS4;LFNG;COMP;PARD6B;CREB3L3;IBSP;CREB3L1;COL4A4;ITGA10;COL4A3;CHAD;ITGA8;TLR3;ITGA9
228,KEGG_2021_Human,Non-small cell lung cancer,2/72,0.9805286636485132,0.9999955952317446,0,0,0.3338546876420842,0.0065647182874352,RET;MET
229,KEGG_2021_Human,Alcoholism,8/186,0.981827981596236,0.9999955952317446,0,0,0.524076533725814,0.0096111220744426,SHC3;CREB3L3;CREB3L1;PPP1R1B;CRH;GNG11;SLC6A3;GRIN1
230,KEGG_2021_Human,N-Glycan biosynthesis,1/50,0.9834418545710176,0.9999955952317446,0,0,0.2385885651970712,0.003983656924433,MGAT4A
231,KEGG_2021_Human,mTOR signaling pathway,6/154,0.9845657653918302,0.9999955952317446,0,0,0.4729039824764138,0.0073558239294886,DEPTOR;FZD4;RPS6KA2;EIF4E1B;FNIP2;LPIN2
232,KEGG_2021_Human,Chronic myeloid leukemia,2/76,0.9853130762630607,0.9999955952317446,0,0,0.3157396734736009,0.0046716350764135,SHC3;TGFBR2
233,KEGG_2021_Human,Glycosaminoglycan biosynthesis,1/53,0.9870574742545862,0.9999955952317446,0,0,0.2247871403405754,0.002928304321278,B3GNT7
234,KEGG_2021_Human,Melanogenesis,3/101,0.9882978826221106,0.9999955952317446,0,0,0.357383335499805,0.0042068042891882,CREB3L3;FZD4;CREB3L1
235,KEGG_2021_Human,Olfactory transduction,23/440,0.9885703007603712,0.9999955952317446,0,0,0.6408756865475361,0.0073671994489239,OR5AU1;OR10H1;OR4E1;OR2D2;OR52I2;OR52H1;OR52I1;OR10G2;PDE1C;ARRB1;OR10AD1;OR6T1;OR52N2;OR2AG1;OR5AN1;OR2B11;CNGA3;OR10A2;OR13D1;CNGA4;OR6A2;OR4C6;OR2A4
236,KEGG_2021_Human,Tuberculosis,7/180,0.9897744445493049,0.9999955952317446,0,0,0.4716482478093002,0.0048476929454486,C3;HLA-DRB5;HLA-DMA;MRC1;LBP;HLA-DPA1;HLA-DQB1
237,KEGG_2021_Human,Hippo signaling pathway,6/163,0.990448907088862,0.9999955952317446,0,0,0.445575341741898,0.0042761852728357,PARD6B;FZD4;GDF5;BMP6;BMP5;TGFBR2
238,KEGG_2021_Human,Breast cancer,5/147,0.991879203531346,0.9999955952317446,0,0,0.4106109873526875,0.0033481013558788,SHC3;FGF9;FZD4;FGF18;ESR1
239,KEGG_2021_Human,Prion disease,12/273,0.9922986754682523,0.9999955952317446,0,0,0.5350534213994861,0.0041365690947867,ND6;C5;C6;TUBA3C;CREB3L3;CAV3;CREB3L1;CACNA1D;C8B;NDUFV2;C8A;GRIN1
240,KEGG_2021_Human,Hepatocellular carcinoma,6/168,0.9927252771530872,0.9999955952317446,0,0,0.4317048382140915,0.0031520120081512,SHC3;GSTA5;FZD4;GSTA2;MET;TGFBR2
241,KEGG_2021_Human,Colorectal cancer,2/86,0.992807366679252,0.9999955952317446,0,0,0.278000060622594,0.0020067781918561,EREG;TGFBR2
242,KEGG_2021_Human,FoxO signaling pathway,4/131,0.993519996482358,0.9999955952317446,0,0,0.3673536983785249,0.002388199411991,G6PC1;SGK2;KLF2;TGFBR2
243,KEGG_2021_Human,Neutrophil extracellular trap formation,7/189,0.9936044995630804,0.9999955952317446,0,0,0.4481039394832498,0.0028750524716026,C3;FGB;FGA;C5;FGG;AZU1;ELANE
244,KEGG_2021_Human,Gap junction,2/88,0.9937728584089036,0.9999955952317446,0,0,0.2715053365505603,0.0016959882505426,TUBA3C;HTR2B
245,KEGG_2021_Human,Kaposi sarcoma-associated herpesvirus infection,7/193,0.9948282155933548,0.9999955952317446,0,0,0.4383711668657905,0.0022730440917514,C3;CSF2;BECN2;IL6ST;GNG11;TLR3;ICAM1
246,KEGG_2021_Human,Pathways in cancer,27/531,0.9957524123228384,0.9999955952317446,0,0,0.6210612640916652,0.0026436306818349,RET;CSF3R;HHIP;PTGER2;CSF2RA;KNG1;FGF9;DAPK1;FZD4;ZBTB16;VEGFD;F2;GNG11;ESR1;AGT;IL2;EPOR;TGFBR2;GSTA5;GSTA2;COL4A4;COL4A3;FGF18;AGTR1;BIRC7;IL6ST;MET
247,KEGG_2021_Human,Neurotrophin signaling pathway,3/119,0.9964251123562444,0.9999955952317446,0,0,0.3016307928838129,0.0010802281941563,SHC3;RPS6KA2;PSEN2
248,KEGG_2021_Human,Apoptosis,4/142,0.9967308492272476,0.9999955952317446,0,0,0.337868669234535,0.0011063530254864,TUBA3C;BECN2;CTSH;BIRC7
249,KEGG_2021_Human,Fc gamma R-mediated phagocytosis,2/97,0.99676031320475,0.9999955952317446,0,0,0.2456631712955208,0.0007971637108548762,SCIN;PLA2G4A
250,KEGG_2021_Human,Phosphatidylinositol signaling system,2/97,0.99676031320475,0.9999955952317446,0,0,0.2456631712955208,0.0007971637108548762,ITPKA;MTMR7
251,KEGG_2021_Human,Epithelial cell signaling in Helicobacter pylori infection,1/70,0.9967968389849504,0.9999955952317446,0,0,0.1692480731644356,0.0005429989513888203,MET
252,KEGG_2021_Human,RIG-I-like receptor signaling pathway,1/70,0.9967968389849504,0.9999955952317446,0,0,0.1692480731644356,0.0005429989513888203,IFNK
253,KEGG_2021_Human,Diabetic cardiomyopathy,7/203,0.9969874480716284,0.9999955952317446,0,0,0.4157772304324028,0.0012544409817632,ND6;PDK4;AGTR1;REN;NDUFV2;AGT;TGFBR2
254,KEGG_2021_Human,Proteoglycans in cancer,7/205,0.9973002442808188,0.9999955952317446,0,0,0.4115323090418876,0.001112539173621,CAV3;FZD4;ERBB4;KDR;IHH;ESR1;MET
255,KEGG_2021_Human,Glioma,1/75,0.9978756612925064,0.9999955952317446,0,0,0.157769410632006,0.00033551216291082073,SHC3
256,KEGG_2021_Human,Osteoclast differentiation,3/127,0.997916169666358,0.9999955952317446,0,0,0.2820474625025683,0.0005883522841826568,CALCR;LILRA2;TGFBR2
257,KEGG_2021_Human,Pancreatic cancer,1/76,0.9980431467958176,0.9999955952317446,0,0,0.155657336726039,0.00030489697482772573,TGFBR2
258,KEGG_2021_Human,C-type lectin receptor signaling pathway,2/104,0.9980603802598008,0.9999955952317446,0,0,0.2287165661936321,0.0004440539539578307,CCL17;IL2
259,KEGG_2021_Human,Toll-like receptor signaling pathway,2/104,0.9980603802598008,0.9999955952317446,0,0,0.2287165661936321,0.0004440539539578307,LBP;TLR3
260,KEGG_2021_Human,RNA degradation,1/79,0.998470395913362,0.9999955952317446,0,0,0.1496460494552097,0.00022907445010120423,ENO3
261,KEGG_2021_Human,B cell receptor signaling pathway,1/81,0.9987019886360686,0.9999955952317446,0,0,0.1458889949109414,0.00018948857905340787,LILRA2
262,KEGG_2021_Human,Autophagy,3/137,0.9989478803668208,0.9999955952317446,0,0,0.2608565452989828,0.0002745967724239393,DEPTOR;DAPK1;BECN2
263,KEGG_2021_Human,Epstein-Barr virus infection,6/202,0.9989553946248352,0.9999955952317446,0,0,0.3561530547126317,0.0003722338479395012,HLA-DRB5;HLA-DMA;ENTPD8;ICAM1;HLA-DPA1;HLA-DQB1
264,KEGG_2021_Human,Viral carcinogenesis,6/203,0.9990153251698805,0.9999955952317446,0,0,0.3543257347772425,0.0003490675199173419,C3;SCIN;CREB3L3;CREB3L1;HPN;IL6ST
265,KEGG_2021_Human,Hepatitis B,4/162,0.9990914248475732,0.9999955952317446,0,0,0.294777775088543,0.00026794950650627016,CREB3L3;CREB3L1;TLR3;TGFBR2
266,KEGG_2021_Human,Pathways of neurodegeneration,21/475,0.9991176520784144,0.9999955952317446,0,0,0.5356638017166993,0.00047285048212457646,DNAH12;ND6;DNAI2;DNAH10;DNAH2;DNAH7;FZD4;LRRK2;BECN2;DNAH5;DNAH6;PSEN2;CACNA1D;DNAH9;SLC6A3;DNALI1;GRIN1;TUBA3C;NDUFV2;DNAI1;GRIA4
267,KEGG_2021_Human,Spinocerebellar ataxia,3/143,0.9993044588748023,0.9999955952317446,0,0,0.2495950864422202,0.0001736640495156955,BEAN1;BECN2;GRIN1
268,KEGG_2021_Human,Endocytosis,8/252,0.9994174200973088,0.9999955952317446,0,0,0.3809354213586131,0.0002219899904406702,GRK1;DNM3;PARD6B;CAV3;PIP5KL1;ARRB1;FOLR1;TGFBR2
269,KEGG_2021_Human,mRNA surveillance pathway,1/98,0.999677337393596,0.9999955952317446,0,0,0.1202093334382623,3.8793315754073834e-05,NCBP2L
270,KEGG_2021_Human,Progesterone-mediated oocyte maturation,1/100,0.9997258566316012,0.9999955952317446,0,0,0.1177680108977819,3.228974540919967e-05,RPS6KA2
271,KEGG_2021_Human,Oxidative phosphorylation,2/133,0.999774471606622,0.9999955952317446,0,0,0.1778028289464094,4.010410882796191e-05,ND6;NDUFV2
272,KEGG_2021_Human,RNA transport,4/186,0.9998123072716896,0.9999955952317446,0,0,0.2555697966787832,4.797309465374146e-05,NUP210L;NCBP2L;EIF4E1B;EEF1A2
273,KEGG_2021_Human,Yersinia infection,2/137,0.9998324388966632,0.9999955952317446,0,0,0.1724968762524459,2.890618875109352e-05,RPS6KA2;IL2
274,KEGG_2021_Human,Ubiquitin mediated proteolysis,2/140,0.9998658111508504,0.9999955952317446,0,0,0.1687192686279393,2.264176365662998e-05,BIRC7;RHOBTB2
275,KEGG_2021_Human,NOD-like receptor signaling pathway,3/181,0.999949631558885,0.9999955952317446,0,0,0.1959028125670937,9.867567788127552e-06,CASR;NLRP12;TXNIP
276,KEGG_2021_Human,Cellular senescence,2/156,0.9999578551854448,0.9999955952317446,0,0,0.1510577264873891,6.366434026994424e-06,CACNA1D;TGFBR2
277,KEGG_2021_Human,Necroptosis,2/159,0.999965765117506,0.9999955952317446,0,0,0.1481469468511678,5.0718801353985164e-06,PLA2G4A;TLR3
278,KEGG_2021_Human,Herpes simplex virus 1 infection,18/498,0.9999673368548996,0.9999955952317446,0,0,0.4328054662379421,1.4137018625035108e-05,ZNF540;HLA-DRB5;ZNF99;C3;ZNF90;C5;HLA-DMA;ZNF729;ZNF727;ZNF429;ZNF208;ZNF578;ZNF214;ZNF676;TLR3;HLA-DPA1;ZNF486;HLA-DQB1
279,KEGG_2021_Human,Lipid and atherosclerosis,4/215,0.9999708300666156,0.9999955952317446,0,0,0.2200936993103948,6.420212186275548e-06,CD40LG;LBP;APOB;ICAM1
280,KEGG_2021_Human,Oocyte meiosis,1/129,0.9999718697576736,0.9999955952317446,0,0,0.0909420722010178,2.5582585110638825e-06,RPS6KA2
281,KEGG_2021_Human,Parkinson disease,5/249,0.9999829836747222,0.9999955952317446,0,0,0.237629119270659,4.043608792775245e-06,ND6;TUBA3C;LRRK2;NDUFV2;SLC6A3
282,KEGG_2021_Human,Human cytomegalovirus infection,4/225,0.9999834479260804,0.9999955952317446,0,0,0.2100193511733271,3.476284595105593e-06,CREB3L3;CREB3L1;PTGER2;GNG11
283,KEGG_2021_Human,Measles,1/139,0.9999857385902352,0.9999955952317446,0,0,0.0843059704244569,1.2023305633358629e-06,IL2
284,KEGG_2021_Human,Spliceosome,1/150,0.9999921426230864,0.9999955952317446,0,0,0.078035076933586,6.131534208461047e-07,NCBP2L
285,KEGG_2021_Human,Shigellosis,4/246,0.9999930411777452,0.9999955952317446,0,0,0.1915733029934316,1.333129202778344e-06,C3;CSF2;HKDC1;BECN2
286,KEGG_2021_Human,Alzheimer disease,9/369,0.9999934352023604,0.9999955952317446,0,0,0.2887947570332481,1.8958853623295712e-06,ND6;TUBA3C;FZD4;BECN2;PSEN2;LPL;CACNA1D;NDUFV2;GRIN1
287,KEGG_2021_Human,Non-alcoholic fatty liver disease,1/155,0.9999935876422448,0.9999955952317446,0,0,0.0754808168930306,4.840115533956805e-07,NDUFV2
288,KEGG_2021_Human,MicroRNAs in cancer,6/310,0.9999945206769943,0.9999955952317446,0,0,0.2282647029187519,1.2507394646870826e-06,TRIM71;TNXB;CYP24A1;EFNA5;MET;FOXP1
289,KEGG_2021_Human,Salmonella infection,3/249,0.9999955673847936,0.9999955952317446,0,0,0.1412226192325617,6.259869168684492e-07,TUBA3C;FHOD1;PAK3
290,KEGG_2021_Human,Human immunodeficiency virus 1 infection,2/212,0.9999955873610552,0.9999955952317446,0,0,0.1104361795641235,4.87316062022489e-07,PAK3;GNG11
291,KEGG_2021_Human,Protein processing in endoplasmic reticulum,1/171,0.9999955952317446,0.9999955952317446,0,0,0.0683168687322257,3.009206374407371e-07,UBQLN3
